Table 6.16Evidence profile for ampicillin-sulbactam followed by amoxicillin-clavulanic acid or ampicillin followed by amoxicillin compared with placebo in women with preterm prelabour rupture of membranes

Number of studiesNumber of babies/womenEffectQuality
Ampicillin- sulbactam followed by amoxicillin- clavulanic acid or ampicillin followed by amoxicillinPlaceboRelative (95% confidence interval)Absolute (95% confidence interval)
Confirmed or suspected neonatal sepsis
1 (Lovett 1997)6/75
(8%)
6/37
(16%)
RR 0.49 (0.17 to 1.43)*83 fewer per 1000 (from 135 fewer to 70 more)*Low
Fetal or postnatal mortality
1 (Lovett 1997)0/75
(0%)
3/37
(8%)
RR 0.07 (0.00 to 1.35)*75 fewer per 1000 (from 81 fewer to 28 more)*Moderate

RR relative risk

*

Calculated by the NCC-WCH technical team from data reported in the article

See the complete GRADE Table J 6.16

From: 6, Intrapartum antibiotics

Cover of Antibiotics for Early-Onset Neonatal Infection
Antibiotics for Early-Onset Neonatal Infection: Antibiotics for the Prevention and Treatment of Early-Onset Neonatal Infection.
NICE Clinical Guidelines, No. 149.
National Collaborating Centre for Women's and Children's Health (UK).
London: RCOG Press; 2012 Aug.
Copyright © 2012, National Collaborating Centre for Women’s and Children’s Health.

No part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.